GC protein-derived macrophage-activating factor decreases α-N-acetylgalactosaminidase levels in advanced cancer patients

α-N-acetylgalactosaminidase (nagalase) accumulates in the serum of cancer patients and its activity correlates with tumor burden, aggressiveness and clinical disease progression. The administration of GC protein-derived macrophage-activating factor (GcMAF) to cancer patients with elevated levels of...

Descripción completa

Detalles Bibliográficos
Autores principales: Thyer, Lynda, Ward, Emma, Smith, Rodney, Branca, Jacopo JV, Morucci, Gabriele, Gulisano, Massimo, Noakes, David, Eslinger, Robert, Pacini, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812199/
https://www.ncbi.nlm.nih.gov/pubmed/24179708
http://dx.doi.org/10.4161/onci.25769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812199/
https://www.ncbi.nlm.nih.gov/pubmed/24179708
http://dx.doi.org/10.4161/onci.25769

Ejemplares similares